Synthetic Studies on an Antitumor Antibiotic, Bleomycin. XII. Preparation of an L-2, 3-Diaminopropionic Acid Derivative as a Synthetic Intermediate
Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis of bleomycin.
Saved in:
Published in | Chemical & pharmaceutical bulletin Vol. 33; no. 2; pp. 509 - 514 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Tokyo
The Pharmaceutical Society of Japan
1985
公益社団法人日本薬学会 Maruzen |
Subjects | |
Online Access | Get full text |
ISSN | 0009-2363 1347-5223 |
DOI | 10.1248/cpb.33.509 |
Cover
Loading…
Abstract | Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis of bleomycin. |
---|---|
AbstractList | Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis of bleomycin. |
Author | OTSUKA, MASAMI KITTAKA, ATSUSHI OHNO, MASAJI YAMASHITA, HARUO KOBAYASHI, SUSUMU IIMORI, TAKAMASA |
Author_FL | OTSUKA MASAMI KOBAYASHI SUSUMU IIMORI TAKAMASA YAMASHITA HARUO KITTAKA ATSUSHI OHNO MASAJI |
Author_FL_xml | – sequence: 1 fullname: OTSUKA MASAMI – sequence: 2 fullname: KITTAKA ATSUSHI – sequence: 3 fullname: IIMORI TAKAMASA – sequence: 4 fullname: YAMASHITA HARUO – sequence: 5 fullname: KOBAYASHI SUSUMU – sequence: 6 fullname: OHNO MASAJI |
Author_xml | – sequence: 1 fullname: YAMASHITA, HARUO – sequence: 1 fullname: KITTAKA, ATSUSHI – sequence: 1 fullname: IIMORI, TAKAMASA – sequence: 1 fullname: OTSUKA, MASAMI – sequence: 1 fullname: OHNO, MASAJI – sequence: 1 fullname: KOBAYASHI, SUSUMU |
BackLink | https://cir.nii.ac.jp/crid/1571698602415100160$$DView record in CiNii http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=9145665$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/2410151$$D View this record in MEDLINE/PubMed |
BookMark | eNptkUtrGzEUhUVJSZ20m-4LWpQuSsbVY6QZLV2nD4OhhbTQ3XBHvm4UZjSOJAf8O_qHq4kHB0o3kuB89-hwzwU584NHQl5zNueirD_YXTuXcq6YeUZmXJZVoYSQZ2TGGDOFkFq-IBcx3jEmFKvkOTkXJWdc8Rn5c3Pw6RaTs_Qm7TcOIx08BU8XPrm074fw-GrdkJEr-rHDoT9Y5-f012o1p98D7iBAcnlo2I5z60JcUVlcO-idH3Zh2GUtuy-s29BrDO4h0w9IIVKgT5-vfMLQ48ZBwpfk-Ra6iK-m-5L8_Pzpx_Jrsf72ZbVcrAsr69IUUqPQWNuSKbWRpTTbGhTjaBCB15zJujVGGWwZ1sbWooVKSW7bsgSLrNzIS_Lu6JtT3u8xpqZ30WLXgcdhH5tKC650xTP4ZgL3bc7Y7ILrIRyaaYtZfzvpEC102wDeunjCDC-V1ipj74-YDUOMAbcngrNmLLLJRTZSNrnIDLN_YOvS46JTANf9f2SK4Z3L9HhyVXFtas1yVMUZ45plbHnE7mKC33gKASEX0eHoyI2qR1dxPLL5k3oLoUEv_wLsVsHq |
CODEN | CPBTAL |
CitedBy_id | crossref_primary_10_1002_pep2_24058 crossref_primary_10_1016_j_tet_2005_04_046 crossref_primary_10_3987_COM_04_10214 crossref_primary_10_1016_S0960_894X_01_80184_0 crossref_primary_10_1002_psc_2968 crossref_primary_10_1016_j_jfluchem_2005_04_008 crossref_primary_10_1016_S0040_4039_00_98029_8 crossref_primary_10_1021_ja012741l crossref_primary_10_1016_S0040_4020_88_90018_X crossref_primary_10_1021_jo9904718 crossref_primary_10_1016_S0040_4039_00_84868_6 crossref_primary_10_3390_molecules25061313 crossref_primary_10_1016_S0040_4020_01_00090_4 crossref_primary_10_1021_cr100127y crossref_primary_10_1021_ol026782d crossref_primary_10_1016_0040_4039_95_01544_2 crossref_primary_10_1016_S0957_4166_00_86019_X crossref_primary_10_1021_ja412298c crossref_primary_10_1002_ange_200500927 crossref_primary_10_1002_jlac_1991199101227 crossref_primary_10_1021_jo9702756 crossref_primary_10_1021_jo951958t crossref_primary_10_1021_jo961598p crossref_primary_10_1021_jo9612537 crossref_primary_10_1002_jhet_5570340516 crossref_primary_10_1016_S0040_4020_01_86376_6 crossref_primary_10_1248_cpb_49_1272 crossref_primary_10_1002_ejoc_201000042 crossref_primary_10_1016_j_tet_2009_07_054 crossref_primary_10_1016_S0040_4020_88_90017_8 crossref_primary_10_1021_cr0406561 crossref_primary_10_1016_0040_4020_95_00446_F crossref_primary_10_1016_j_tet_2004_06_034 crossref_primary_10_1002_anie_200500927 crossref_primary_10_1016_S0040_4039_00_60843_2 crossref_primary_10_1021_jo061692y crossref_primary_10_1002__SICI_1099_0690_199805_1998_5_777__AID_EJOC777_3_0_CO_2_W crossref_primary_10_1080_00397910600948039 crossref_primary_10_1002_chin_198529335 crossref_primary_10_1021_jo000071g crossref_primary_10_1002_ejoc_201200496 |
ContentType | Journal Article |
Copyright | The Pharmaceutical Society of Japan 1985 INIST-CNRS |
Copyright_xml | – notice: The Pharmaceutical Society of Japan – notice: 1985 INIST-CNRS |
DBID | RYH AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 |
DOI | 10.1248/cpb.33.509 |
DatabaseName | CiNii Complete CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology Chemistry |
EISSN | 1347-5223 |
EndPage | 514 |
ExternalDocumentID | 2410151 9145665 10_1248_cpb_33_509 110003625401 article_cpb1958_33_2_33_2_509_article_char_en |
Genre | Journal Article |
GroupedDBID | --- .55 .GJ 2WC 3O- 53G 5GY 6J9 ACGFO ACIWK ACPRK ADBBV AENEX AFRAH AI. ALMA_UNASSIGNED_HOLDINGS BAWUL CS3 DIK DU5 EBS EJD F5P GX1 HH5 JSF JSH KQ8 L7B OK1 P2P RJT RZJ TKC TR2 VH1 X7M ZGI RYH 29B AAYXX BKOMP CITATION E3Z JMI MOJWN X7J XSB ZE2 ZY4 ABTAH IQODW CGR CUY CVF ECM EIF NPM 7X8 |
ID | FETCH-LOGICAL-c3849-36e26e8c4055d3439f8a501e9eea181038b9959eb0e89c82ba7531cb44ace04d3 |
ISSN | 0009-2363 |
IngestDate | Fri Jul 11 06:30:39 EDT 2025 Sat Sep 28 08:35:07 EDT 2024 Wed Apr 02 07:12:59 EDT 2025 Thu Apr 24 22:51:15 EDT 2025 Tue Jul 01 03:06:12 EDT 2025 Fri Jun 27 00:06:37 EDT 2025 Wed Sep 03 06:19:33 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | Diamine Antibiotic Aminoamide Aliphatic compound Aminoacid Saturated compound Hofmann reaction |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3849-36e26e8c4055d3439f8a501e9eea181038b9959eb0e89c82ba7531cb44ace04d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.jstage.jst.go.jp/article/cpb1958/33/2/33_2_509/_article/-char/en |
PMID | 2410151 |
PQID | 76215671 |
PQPubID | 23479 |
PageCount | 6 |
ParticipantIDs | proquest_miscellaneous_76215671 pubmed_primary_2410151 pascalfrancis_primary_9145665 crossref_primary_10_1248_cpb_33_509 crossref_citationtrail_10_1248_cpb_33_509 nii_cinii_1571698602415100160 jstage_primary_article_cpb1958_33_2_33_2_509_article_char_en |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 1900 |
PublicationDate | 19850000 |
PublicationDateYYYYMMDD | 1985-01-01 |
PublicationDate_xml | – year: 1985 text: 19850000 |
PublicationDecade | 1980 |
PublicationPlace | Tokyo |
PublicationPlace_xml | – name: Tokyo – name: Japan |
PublicationTitle | Chemical & pharmaceutical bulletin |
PublicationTitleAlternate | Chem. Pharm. Bull. |
PublicationYear | 1985 |
Publisher | The Pharmaceutical Society of Japan 公益社団法人日本薬学会 Maruzen |
Publisher_xml | – name: The Pharmaceutical Society of Japan – name: 公益社団法人日本薬学会 – name: Maruzen |
References | 10) L. Benoiton, Can. J. Chem., 46, 1549 (1968). 8) J. P. Greenstein and M. Winitz, "Chemistry of the Amino Acids," Vol. III, John Wiley-and Sons, Inc., New York, 1961, p. 2463. d) Part IV: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Umezawa, and H. Morishima, Tetrahedron Lett., 22, 2109 (1981 9) S. Takagi, H. Tsukatani, and K. Hayashi, Chem. Pharm. Bull., 7, 616 (1959). 13) H. Yamashita, T. Iimori, M. Otsuka, S. Kobayashi, and M. Ohno, Abstracts of Papers, 103rd Annual Meeting of the Pharmaceutical Society of Japan, Tokyo, April 1983, p. 198. Hecht, Springer-Verlag, New York, 1979, p. 63 2) T. Takita, Y. Muraoka, T. Nakatani, A. Fujii, Y. Umezawa, H. Naganawa, and H. Umezawa, J. Antibiot., 26, 801 (1978). c) Part III: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 22, 671 (1981 g) Part VII: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Naganawa, H. Umezawa, T. Tsuchiya, T. Miyabe, S. Kageyama, S. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, M. Narita, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 521 (1982 f) Part VI: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Tsuchiya, T. Miyake, and S. Umezawa, Proceedings of the Seventh American Peptide Symposium, ed. by D. H. Rich and E. Gross, 1981, p. 29 k) Part XI: H. Umezawa, T. Takita, Y. Sugiura, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron, 40, 501 (1984). b) R. B. Sykes, C. M. Cimarusti, D. P. Bonner, K. Bush, D. M. Floyd, N. H. Georgopapadakou, W. H. Koster, W. C. Liu, W. L. Principe, M. L. Rathnum, W. A. Slusarchyk, W. H. Trejo, and J. J. Wells, Nature (London), 291, 498 (1981). 5) T. Kitagawa, T. Ozasa, and H. Taniyama, Yakugaku Zasshi, 89, 285 (1969). h) Part VIII: M. Narita, M. Otsuka, S. Kobayashi, M. Ohno, Y. Umezawa, H. Morishima, S. Saito, T. Takita, and H. Umezawa, Tetrahedron Lett., 23, 525 (1982 i) Part IX: S. Saito, Y. Umezawa, H. Morishima, T. Takita, H. Umezawa, M. Narita, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 529 (1982 e) Part V: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Sugiura, T. Takita, and H. Umezawa, J. Am. Chem. Soc., 103, 6986 (1981 4) a) A. Imada, K. Kitano, K. Kintaka, M. Muroi, and M. Asai, Nature (London), 289, 590 (1981 6) a) P. Karrer and A. Schlosser, Helv. Chim. Acta, 6, 441 (1923 11) I. Photaki, J. Am. Chem. Soc., 85, 1123 (1963). 7) J. Rundiger, K. Poduska, and M. Zaoral, Collect. Czech. Chem. Commun., 25, 2022 (1960). b) F. Schneider, Justus Liebigs Ann. Chem., 529, 1 (1937). b) Part II: Y. Umezawa, H. Morishima, S. Saito, T. Takita, H. Umezawa, S. Kobayashi, M. Otsuka, M. Narita, and M. Ohno, J. Am. Chem. Soc., 102, 6630 (1980 1) a) Part I: Y. Umezawa, H. Morishima, T. Yoshioka, M. Otsuka, and M. Ohno, "Bleomycin," ed. by S. M. 12) O. Mitsunobu, Synthesis, 1981, 1. 3) M. Hashimoto, T. Konomi, and T. Kamiya, J. Am. Chem. Soc., 98, 3023 (1976). j) Part X: Y. Sugiura, T. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Takita, and. H. Umezawa, J. Biol. Chem., 258, 1328 (1983 |
References_xml | – reference: 13) H. Yamashita, T. Iimori, M. Otsuka, S. Kobayashi, and M. Ohno, Abstracts of Papers, 103rd Annual Meeting of the Pharmaceutical Society of Japan, Tokyo, April 1983, p. 198. – reference: j) Part X: Y. Sugiura, T. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Takita, and. H. Umezawa, J. Biol. Chem., 258, 1328 (1983); – reference: 6) a) P. Karrer and A. Schlosser, Helv. Chim. Acta, 6, 441 (1923); – reference: 2) T. Takita, Y. Muraoka, T. Nakatani, A. Fujii, Y. Umezawa, H. Naganawa, and H. Umezawa, J. Antibiot., 26, 801 (1978). – reference: d) Part IV: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Umezawa, and H. Morishima, Tetrahedron Lett., 22, 2109 (1981); – reference: b) R. B. Sykes, C. M. Cimarusti, D. P. Bonner, K. Bush, D. M. Floyd, N. H. Georgopapadakou, W. H. Koster, W. C. Liu, W. L. Principe, M. L. Rathnum, W. A. Slusarchyk, W. H. Trejo, and J. J. Wells, Nature (London), 291, 498 (1981). – reference: Hecht, Springer-Verlag, New York, 1979, p. 63; – reference: b) Part II: Y. Umezawa, H. Morishima, S. Saito, T. Takita, H. Umezawa, S. Kobayashi, M. Otsuka, M. Narita, and M. Ohno, J. Am. Chem. Soc., 102, 6630 (1980); – reference: c) Part III: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 22, 671 (1981); – reference: 9) S. Takagi, H. Tsukatani, and K. Hayashi, Chem. Pharm. Bull., 7, 616 (1959). – reference: f) Part VI: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, S. Kobayashi, M. Ohno, T. Tsuchiya, T. Miyake, and S. Umezawa, Proceedings of the Seventh American Peptide Symposium, ed. by D. H. Rich and E. Gross, 1981, p. 29; – reference: 8) J. P. Greenstein and M. Winitz, "Chemistry of the Amino Acids," Vol. III, John Wiley-and Sons, Inc., New York, 1961, p. 2463. – reference: i) Part IX: S. Saito, Y. Umezawa, H. Morishima, T. Takita, H. Umezawa, M. Narita, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 529 (1982); – reference: g) Part VII: T. Takita, Y. Umezawa, S. Saito, H. Morishima, H. Naganawa, H. Umezawa, T. Tsuchiya, T. Miyabe, S. Kageyama, S. Umezawa, Y. Muraoka, M. Suzuki, M. Otsuka, M. Narita, S. Kobayashi, and M. Ohno, Tetrahedron Lett., 23, 521 (1982); – reference: 12) O. Mitsunobu, Synthesis, 1981, 1. – reference: 4) a) A. Imada, K. Kitano, K. Kintaka, M. Muroi, and M. Asai, Nature (London), 289, 590 (1981); – reference: 3) M. Hashimoto, T. Konomi, and T. Kamiya, J. Am. Chem. Soc., 98, 3023 (1976). – reference: 1) a) Part I: Y. Umezawa, H. Morishima, T. Yoshioka, M. Otsuka, and M. Ohno, "Bleomycin," ed. by S. M. – reference: 7) J. Rundiger, K. Poduska, and M. Zaoral, Collect. Czech. Chem. Commun., 25, 2022 (1960). – reference: b) F. Schneider, Justus Liebigs Ann. Chem., 529, 1 (1937). – reference: k) Part XI: H. Umezawa, T. Takita, Y. Sugiura, M. Otsuka, S. Kobayashi, and M. Ohno, Tetrahedron, 40, 501 (1984). – reference: 10) L. Benoiton, Can. J. Chem., 46, 1549 (1968). – reference: h) Part VIII: M. Narita, M. Otsuka, S. Kobayashi, M. Ohno, Y. Umezawa, H. Morishima, S. Saito, T. Takita, and H. Umezawa, Tetrahedron Lett., 23, 525 (1982); – reference: 11) I. Photaki, J. Am. Chem. Soc., 85, 1123 (1963). – reference: e) Part V: M. Otsuka, M. Yoshida, S. Kobayashi, M. Ohno, Y. Sugiura, T. Takita, and H. Umezawa, J. Am. Chem. Soc., 103, 6986 (1981); – reference: 5) T. Kitagawa, T. Ozasa, and H. Taniyama, Yakugaku Zasshi, 89, 285 (1969). |
SSID | ssj0025073 |
Score | 1.2849274 |
Snippet | Three methods have been developed for the preparation of (S)-3-amino-2-tert-butoxycar-bonylaminopropionamide suitably protected for use in the total synthesis... |
SourceID | proquest pubmed pascalfrancis crossref nii jstage |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 509 |
SubjectTerms | (S)-3-amino-2-tert-butoxycarbonylaminopropionamide Alanine - analogs & derivatives Aliphatic compounds beta-Alanine - analogs & derivatives beta-Alanine - chemical synthesis bleomycin Bleomycin - chemical synthesis Chemical Phenomena Chemistry Exact sciences and technology Hofmann rearrangement L-2, 3-diaminopropionic acid L-asparagine L-serine Mitsunobu reaction Organic chemistry Preparations and properties |
Title | Synthetic Studies on an Antitumor Antibiotic, Bleomycin. XII. Preparation of an L-2, 3-Diaminopropionic Acid Derivative as a Synthetic Intermediate |
URI | https://www.jstage.jst.go.jp/article/cpb1958/33/2/33_2_509/_article/-char/en https://cir.nii.ac.jp/crid/1571698602415100160 https://www.ncbi.nlm.nih.gov/pubmed/2410151 https://www.proquest.com/docview/76215671 |
Volume | 33 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
ispartofPNX | Chemical and Pharmaceutical Bulletin, 1985/02/25, Vol.33(2), pp.509-514 |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Zb9QwELbawgMv3BULFCyBK6HdLJs4ThyJl6Rs1RaBimilvkVx4oigNlntgbT8DH4xM0k2h1rEIa0syxkf2fHYM874G0JepyqCfTNNDCfVYKDwJDYiWwgjAVVZm1qpicIvuh8_OUfn9smFuNjavtfxWlot1Tj-ceO9kv_hKpQBX_GW7D9wtmkUCiAP_IUUOAzpX_H4yzoH_Q0hV2t3wGHpW4yIANlydVXMy5zKCiApGXmpi6t1nOXj4cXx8Rj9Lyro70ppxAi-hgWE3HiP973zApbXWVbGyPHjDF2W52UwtO8aw9NEw7b_8mCxvIWy7IMfbPAIcIbNvvbOz1UX-Rt4zqaC-Tbz3TJjMs8fsqnHvIBJgUWBywLeEjvMh4cSSfwAMkMs8qCmg8TykAVWSww0nPmHZS3ITKuWfSadspZk8qA7jMDE39RmATwJhjWNLzbjsdvDEtOrggGNNxftTvtvuXGLhf_3BBSTvLdNeIbF65W33iYqvI5aHKzOmi8mXkd9ENWd2Gs7k2XjbYt4psacj5sqPaRvRO9DhQKUaLDnb1mua-I6_eFz810M9FW3iQ2IA6wBd6Hxt23TPRXr9jewMhA-YjvPMvT8jRbw8mkVteX3ZlWpXp3dJ3dru4j61SR_QLZ0_pDs1__lekTP2nuCixHdp6ct5Pr6EfnZzERaSwItchrltJEE2krCiLZyQFEOaEcOaJFiPZCD0XUpoCgFtJUCGi1oRNu-u1LwmJwfTs8Ojow62ogRc2l7Bne05WgZgwUjEg56eiojMTG1p3UEavCES4XYfFpNtPRiaakILH0zVrYNU2piJ3yX7ORFrp-gu6DkOnGVSJWwbQxwJblrpVHicZ4I6Q7Imw2DwriG4seIMJchmuTAzBCYGXIeAjMH5FVDO6sAaG6kelfxuaGpFyWkQTwppLOqBMjbp8AsWEkHZA9mB4wFU1MgghbGpgPl3iwD0cPz3rxpevFMMMAcMSAvN_MohO0JvzlGuS5WixB0LVM4rjkgu9X0aqpC62CKmE__0PUzcgcFuTr1fE52lvOV3gM7YKlelKLxC5xl9jA |
linkProvider | Colorado Alliance of Research Libraries |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Synthetic+Studies+on+an+Antitumor+Antibiotic%2C+Bleomycin.+XII.+Preparation+of+an+L-2%2C3-Diaminopropionic+Acid+Derivative+as+a+Synthetic+Intermediate&rft.jtitle=Chemical+%26+pharmaceutical+bulletin&rft.au=%E5%A4%A7%E5%A1%9A+%E9%9B%85%E5%B7%B3&rft.au=%E6%A9%98%E9%AB%98+%E6%95%A6%E5%8F%B2&rft.au=%E9%A3%AF%E6%A3%AE+%E9%9A%86%E6%98%8C&rft.au=%E5%B1%B1%E4%B8%8B+%E6%98%A5%E9%9B%84&rft.date=1985&rft.pub=The+Pharmaceutical+Society+of+Japan&rft.issn=0009-2363&rft.volume=33&rft.issue=2&rft.spage=509&rft.epage=514&rft_id=info:doi/10.1248%2Fcpb.33.509&rft.externalDocID=110003625401 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-2363&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-2363&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-2363&client=summon |